Human Papillomavirus Vaccine Controversy : Susan Le

Human papillomavirus (HPV) is a killer. It is an awful disease that is the culprit of many deaths each year. We have the means for its prevention, yet HPV vaccination for girls is a controversial topic to some. This controversy carries over to the current question on whether or not males should also be vaccinated. The issue is starting to play a huge role in the media; Fox news recently broadcasted a story on male HPV vaccinations. This story makes clear the benefits that would come from vaccinating males, including a statement from the Center for Disease Control that, “The HPV vaccine will afford protection against certain HPV-related conditions and cancers in males, and vaccination of males with HPV may also provide indirect protection

What if a young girl cannot afford or choice not to get the vaccine what is the outcome for them, and then if girls get the vaccine can it really stop young girls from getting Cervical cancer. Adams discuss that “ Cervical Cancer is prevented in a hundred other ways, including adequate sunlight exposure and vitamin D consumption, supplementation with probiotics, adequate intake of selenium and zinc, increased consumption of trace minerals and iodine, regular physical exercise and many other safe, natural, non-patented strategies” (447). Does anyone know really if the HPV vaccine will really stop the profit of cervical cancer? The Center of Disease control and Prevention: reported that the number of new cases has fallen to about 50,000 in 2005 according to Morbidity and Mortality Weekly report of March 16 (449). Allen points out that the women who did receive the vaccine had no major side effects. In other case Cervical Cancer strikes 14,000 American women each year killing one-fourth of them (449). If a young girl, a parent doesn’t want their daughter to get the vaccine or even has second thought about it, they should make a doctor appointment yearly to check for Cervical cancer. Then the next thing to do if the young lady does need the HPV vaccine is learn more about the vaccine and decided if they want to go in that direction for their daughter.

There are many reasons that this vaccine could be beneficial, not only to our society, but to many of the underdeveloped nations of the world in which HPV and cervical cancer are still considered to be an epidemic (MacDonald). It could save the young women who get the vaccine from the future trouble of dealing with a highly invasive cancer, as well as protect them from the embarrassment that comes with contracting a venereal disease. However, the controversy of this topic is not in whether the vaccine is a benefit to women’s health, which many, including the FDA and the Centers for Disease Control, believe that it is; but in the debate over whether it is the parents’ right, not the states’, to choose what is best for their child. The question of mandatory vaccination raises medical, moral and legal issues that are not easily reconcilable (Lovinger). Many parents are opposed to the mandating of this vaccine for three reasons. First, HPV is not spread by casual contact, as are the other diseases that children are vaccinated against for the safety of the classrooms. Second, the vaccine has only been approved for a short while, thus not all of the side effects and long term effects are known. Last, parents are afraid that by getting their child vaccinated against a sexually transmitted disease they will be encouraging promiscuity. Gardasil would become the first vaccine mandated for school-aged children that targets a

Gardasil has been tested in thousands of women and found to be nearly 100% effective in protecting against diseases caused by the four HPV types. Side effects are very uncommon and the occurrence is about 1%. Not only are HPV vaccinations safe, and effective but in today’s society it seems that they have become necessary. “An estimated 493,000 cervical cancer cases occur each year with 274,000 deaths. More than 80% of cervical cancer deaths worldwide occur in developing countries. Cervical cancer is the second most common cancer in women”. If there is a cure of this kind of epidemic, it is evident that it is necessary.

Human papillomavirus (HPV) is a sexually-transmitted infection (STI) which includes over forty strains, several of which are the cause of 70% of cervical cancer cases (Thomas, 2008). The Food and Drug Administration licensed the vaccine, Gardasil, produced by the pharmaceutical company, Merck, in June 2006 as a safe and effective means for preventing cervical cancer caused by HPV (Thomas, 2008). The vaccine can be administered in young girls starting at the age of 9 years old and has been recommended for all girls and women between the ages of 13 and 26 years old with the vaccine being most effective prior to beginning sexual activity (Thomas, 2008). Compulsory vaccination mandates require vaccination of particular individuals and have been proposed as a means to achieving profound levels of HPV immunization throughout female adolescent populations within the United States (Balog, 2009). This paper will focus on a discussion of the current debate surrounding compulsory HPV vaccination mandates, the ethical principles underlying the issue, and how this issue relates to the practice of professional nursing.

Cervical cancer is met with a vaccine with both pros and cons to suppress and annihilate it indefinitely. Although both Mike Adams and Arthur Allen inform the audience of the HPV vaccine, Adams vigorously argues, without evidence, that the vaccine is dangerous to humans while Allen is more sedate and discusses opposing sides to the vaccine. The HPV vaccine has its pros and cons to people that it has created debates to come down to the conclusion of a better solution for the drug companies and the people forcing to receive it. Though the HPV vaccine promises to cure cervical cancer, it has received its fair share of criticism.

Cervical cancer is the leading cause of cancerous death, in women, since 1950. Approximately 200,000 cervical cancer patients die each year in developing countries. Strains like HPV 16 and 18 cause about 70% of cervical cancer in women– one of the top causes of death in the world (WebMD, 2010, p.1). In the Unites States, about 10,000 women acquire the disease and 3,700 die annually Human Papilloma Virus (HPV) is directly associated as a cause of cervical cancer. This virus affects the skin and genital area and, in some cases, it can also infect the throat and mouth. Since the HPV is passed from one person to another through skin-to-skin or sexual contact, sexually active people are more prone to this virus. Merck

As the article dives deeper into the HPV vaccine debate some interesting points were brought up. One thing that was very striking was that cervical cancer kills more than five thousand women in America every year and this number increases in developing countries. It would seem that this is enough of a problem to raise a sense of alarm. Another fact that was given was that HPV is the most common sexually transmitted disease in the United States. A big reason for this is that there are over two hundred strands of HPV and the diversity of this virus helps it to spread. In order for women to be protected against some of the HPV strands she should receive the vaccine before becoming sexually active. This seems to be the push to get girls vaccinated early. Since the average age of first intercourse is under the age of

Genital human papillomavirus (HPV) is the most common sexually transmitted virus in the United States. Most sexually active people will have genital HPV at some time in their lives. Most people who have genital HPV don’t know they have it. There are often no symptoms, and it goes away on its own, without causing any serious health problems. HPV is passed on through genital contact, and you can pass HPV to others without knowing it. There is no cure for HPV, but there

Studies show that the amount of responders was about 100% for both of the vaccines while the magnitude of the responses in CervarixⓇ were usually higher than those in GardasilⓇ. It has been shown in studies protection can last at least 6.4 years for CervarixⓇ and 5 years for GardasilⓇ.5 The purpose of this review is to identify the efficacy and potential risk of HPV vaccines in prevention of Human Papillomavirus 16 and 18 in young girls. We will compare vaccines Gardasil and

After reading the article about the human papillomavirus (HPV), my curiosity spiked. As a mother of 2 girls, I will have to decide soon if the HPV vaccine is one I want my children to receive. I have head multiple arguments for and against the HPV vaccine, but have done little research on my own. As always, it is amazing how many questions can be answered and cleared by a few hours of research and self-education. Some of the amazing facts gathered include the discovery that it only takes one infected sexual partner in an entire lifetime to contract the HPV virus, 80% of sexually active people will contract the disease while experiencing no symptoms, and the virus is contracted via skin to skin contact making it very infectious.

The Human Papillomavirus (HPV) is a common sexually transmitted disease that infects the ano-genital tract of both males and females (Rubin, Kuttab, Rihani, & Reutzel, 2012, p. 1145). “A substantial burden of cancers and anogenital warts are attributable to HPV in the United States: in 2009, an estimated 34,788 new HPV-associated cancers and approximately 355,000 new cases of anogenital warts were associated with HPV infection” (CDC, 2015). The Gardasil quadrivalent vaccine was created to prevent the transmission of HPV. This vaccination is usually administered to adolescents between 11-12 years old and is a three dose series given over the course of six months. As a result of the extended vaccine period many patients are not completing the

This journal article examines that school is a significant situation for HPV vaccination to introduce and argues that coverage rate and the valuable experiences strategy from different countries and performing a deployment. Human Papilloma Virus is the primary risk factor for the disease. In recent decades, cervical cancer can influences 88% female deaths in developing countries. WHO suggests that HPV vaccination will become a part of the national immunization programs, because this vaccine can prevent the death of women in the 60%. So, HPV vaccine delivery strategies are taking place in many regions and they also strongly urge that all women who are between 9-20 years get a full HPV vaccination. (p.320)

HPV also known as human papillomavirus which is an infectious disease. It is a fact that infectious diseases no longer the leading cause of death and has been replaced by chronic disease as the leading cause of death. Two antibodies have market regard in numerous nations starting called Gardasil and Cervix in the US and this essay will analyze all there is to HPV, risks associated with requiring the HPV vaccine in public schools and more.

In 2006 the first human papillomavirus (HPV) vaccine was released for consumer use by the Food and Drug Administration (Krisberg 13). This vaccine was developed in response to the ever-increasing number of cervical cancer cases that were developing in the world after a direct correlation was found between the virus and the disease. Australian professor Ian Frazer was the first individual who learned how to create the vaccine particles utilized in this technology (Daley et al. 983). The vaccine consists of the protein shell coat found in several strains of the virus while the harmful viral DNA and RNA are left out. The Food and Drug Administration then cleared this life-saving vaccine for usage by girls from the ages of eleven to twenty-six.